Primary Record
Imatinib
- In stock
- 809 g
- Purity
- 98.8 %
- CAS
- 152459-95-5
Compound Identifiers & Properties
- CAS
- 152459-95-5
- PubChem CID
- 5291
- SMILES
- CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
- Canonical SMILES
- Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1
Names & Synonyms
- Imatinib
- 152459-95-5
- Glivec
- Gleevec
- Imatinib mesylate
- Glamox
- Imatinib (STI571)
- Imatinib free base
- STI571
- Imatinib mesilate
- sti-571
- Imatinibum
- Imatib
- Imatinib base
- Imatinib [INN:BAN]
- Imatinib (INN)
- imatinib-CD3
- 1iep
- 1xbb
- Glamox (TN)
- Gleevec(TM)
- Imatinib Methansulfonate
- Gleevec (TN)
- Imatinib (Gleevec)
- Imatinib - Gleevec
- Imatinib, 21
- Cgp 57148
- Glivec (TN)
- RefChem:76
- Imatinib (Standard)
- Imatinib, Free base
- GLEVEEC
- BKJ8M8G5HI
- Imatinib base(IMA-3)
- Imatinib(STI571)
- UNII-BKJ8M8G5HI
- Kinome_3724
- STI 571
- ACMC-20a8ej
- IMATINIB 1G
- CHEMBL941
- IMATINIB [INN]
- IMATINIB [MI]
- C29H31N7O
- IMATINIB [VANDF]
- CCRIS 9076
- IMATINIB 100MG
- CGP 57148B
- MFCD05662257
- D01UCI
- D0AZ3C
- IMATINIB [WHO-DD]
- Gleevec (TN) (Novartis)
- AC1L1K0Z
- cid_5291
- SCHEMBL3827
- KTUFNOKKBVMGRW-UHFFFAOYSA-N
- IMATINIB [EMA EPAR]
- CGP-57148
- DTXSID3037125
- STI-571; IMATINIB
- CHEBI:45783
- KSC919A1B
- BIDD:GT0047
- NSC-743414
- NSC-759854
- Imatinib Mesylate (STI571)
- 152459-95-5 (free base)
- GTPL5687
- Imatinib, 98% - 1G 1g
- orb1300957
- N-(4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide
- Tyrosine Kinase Inhibitor - Ns
- DTXCID1017125
- SCHEMBL29351601
- SCHEMBL29355523
- 2,2'-Diallyl-4,4'-biphenol
- BDBM13530
- CGP57148B
- CTK8B9010
- CID5291
- EX-A063
- L01XE01
- QCR-269
- Imatinib =98.0% (by HPLC)
- NSC743414
- ST1571
- BCPP000205
- CGP057148B
- GLXC-05177
- HMS2089D03
- HMS3244P06
- HMS3244P10
- HMS3244P14
- HMS3656K04
- HMS3715P03
- HMS5081I09
- Imatinib base - Bio-X trade mark
- Pharmakon1600-01502276
- AMX10172
- BCP01542
- CGP-57-148B
- CGP57148
- KS-00000GF2
- ST 1571
- STI-5571
- AC-524
- ANW-61817
- BBF-05855
- C29-H31-N7-O
- EBC-06061
- HY-15463R
- MSK159951
- NSC759854
- NSC800772
- STK617705
- VCC905240
- ZINC19632618
- 112GI019
- AKOS000280662
- ACN-034467
- AN-1330
- BCP9000775
- CCG-101289
- CS-0964
- DB00619
- ES-0058
- FM10813
- NSC 743414
- NSC 759854
- NSC-800772
- PA-5291
- RL01949
- RP17985
- RTC-070813
- SB17306
- SDCCGSBI-0634386.P009
- ST-1571
- Imatinib Meta-methyl-piperazine Impurity
- MRF-0000449
- NCGC00159456-01
- NCGC00159456-02
- NCGC00159456-03
- NCGC00159456-04
- NCGC00159456-05
- NCGC00159456-06
- NCGC00159456-07
- NCGC00159456-09
- NCGC00159456-16
- AJ-74092
- AK107630
- BC215796
- BI164570
- EN002706
- HY-15463
- SY028029
- AB0044023
- AB1009645
- LS-182208
- LS-187106
- ST2413554
- 2158B
- A1805
- AM20090646
- B2171
- FT-0651483
- I0906
- NS00009172
- S2475
- SW197805-5
- 220127-57-1
- 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE
- 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide
- J1.337.143A
- A10259
- D08066
- EN300-123057
- W-3956
- 12810-EP2269994A1
- 12810-EP2270008A1
- 12810-EP2272827A1
- 12810-EP2275412A1
- 12810-EP2275413A1
- 12810-EP2277865A1
- 12810-EP2287156A1
- 12810-EP2289892A1
- 12810-EP2291366A2
- 12810-EP2292234A1
- 12810-EP2292617A1
- 12810-EP2305667A2
- 12810-EP2308855A1
- 12810-EP2311807A1
- 12810-EP2311821A1
- 12810-EP2311840A1
- 12810-EP2316831A1
- 12810-EP2316832A1
- 12810-EP2316833A1
- 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
- AB00698388-07
- AB00698388-10
- AB00698388-11
- AB00698388-12
- AB00698388-13
- AB00698388_15
- AB00698388_16
- 459I955
- A809313
- Q177094
- SR-01000763561
- I01-1232
- N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide
- SR-01000763561-4
- SR-01000763561-6
- BRD-K92723993-001-06-7
- BRD-K92723993-001-12-5
- BRD-K92723993-066-02-9
- BRD-K92723993-066-04-5
- BRD-K92723993-066-22-7
- 4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide
- Benzamide, 4-((4-methyl)-1-piperazinyl)methyl)-N-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)-
- Z1546624232
- alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide
- alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-toluidide
- 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide
- 4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide
- MCL-1-specific antisense oligonucleotide + Imatinib (STI571)
- STI
- Pyrimidine,4-(bromomethyl)-2-chloro-; 4-(Bromomethyl)pyrimidine
- 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide methanesulfonate
- 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]phenyl]benzamide
- N-(3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-4-methylphenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide
- N-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide
- 1080014-82-9
- 1092942-82-9
- 1134803-18-1
- 4-((4-Methyl-1-piperazinyl)methyl)-N-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)benzamide
- 4-(4-Me-piperazin-1-ylmethyl)-N-[4-Me-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide
- 4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide
- 4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide; CGP 57148; Genfatinib; Imatinib, Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-
- 4-(4-Methylpiperazinomethyl)-N-[4-methyl-3-[4-(3-pyridyl)-2-pyrimidinylamino]phenyl]benzamide
- 4-[(4-methyl-1-piperazinyl)-methyl]-N-{4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]-amino]-phenyl)-benzamide
- 4-[(4-methyl-1-piperazinyl)-methyl]-N-{4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]-amino]-phenyl}-benzamide
- 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[(4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide
- 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide
- 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3- pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide
- 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide
- 4-[(4-methyl-1-piperazinyl)methyl]-n[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide
- 4-[(4-Methylpiperazine-1-yl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)pyrimidine-2-yl]amino]phenyl]benzamide
- BENZAMIDE, 4-((4-METHYL-1-PIPERAZINYL)METHYL)-N-(4-METHYL-3-((4-(3-PYRIDINYL)-2-PYRIMIDINYL)AMINOPHENYL)-
- benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-
- Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]- (9CI)
- Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-(9CI)
- Benzamide,4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-
- N-[3-[[4-(3-Pyridinyl)pyrimidine-2-yl]amino]-4-methylphenyl]-4-(4-methylpiperazine-1-ylmethyl)benzamide
- N-[3-[[4-(3-Pyridinyl)pyrimidine-2-yl]amino]-4-methylphenyl]-4-[(4-methylpiperazine-1-yl)methyl]benzamide
- N-[3-[4-(3-Pyridinyl)-2-pyrimidinylamino]-4-methylphenyl]-4-(4-methylpiperazinomethyl)benzamide
- N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]-4-[(2,2,3,3,5,5,6,6-octadeuterio-4-methylpiperazin-1-yl)methyl]benzamide
- N-[4-Methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]-4-[[4-(trideuteriomethyl)piperazin-1-yl]methyl]benzamide
- N-[4-Methyl-3-[[4-(3-pyridyl)-2-pyrimidyl]amino]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]benzamide
- N-[5-[4-(4-methylpiperazinomethyl)benzoylamido]-2-methylphenyl]-4-(3-pyridyl)-2-pyrimidineamine